MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Atai Beckley N.V - Common Shares (NQ:ATAI)

4.090 -0.100 (-2.39%)
Streaming Delayed Price Updated: 2:02 PM EST, Dec 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,746,712
Open 4.200
Bid (Size) 4.080 (3,000)
Ask (Size) 4.090 (1,000)
Prev. Close 4.190
Today's Range 4.020 - 4.200
52wk Range 1.150 - 6.750
Shares Outstanding 166,010,476
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
MarketBeat’s Top 5 Rated Small-Cap Stocks ↗
Via MarketBeat

Performance

YTD
+155.6%
+155.6%
1 Month
+8.8%
+8.8%
3 Month
-20.9%
-20.9%
6 Month
+81.8%
+81.8%
1 Year
+227.2%
+227.2%

More News

Read More
News headline image
Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗
Via Stocktwits
Topics Cannabis ETFs Government
News headline image
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
From AtaiBeckley N.V.
Via GlobeNewswire
News headline image
Analyst Expectations For ATAI Life Sciences's Future ↗
Via Benzinga
News headline image
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
Why Atai Life Sciences Stock Was So Lively This Week ↗
Via The Motley Fool
News headline image
atai Life Sciences Announces Pricing of Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences Announces Proposed Public Offering of Common Shares
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
News headline image
Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides
Via MarketMinute
Topics Earnings Economy Intellectual Property
News headline image
Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside ↗
Via Benzinga
News headline image
Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews ↗
Via Benzinga
News headline image
Why Atai Life Sciences Stock Crushed It on Tuesday ↗
Via The Motley Fool
News headline image
Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients ↗
Via Benzinga
News headline image
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
From atai Life Sciences
Via GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Cathie Wood's Ark Bets Big On Solana Treasury Play: Makes $162M Investment In Brera Holdings As Stock Explodes 225% ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
atai Life Sciences Awarded Grant from the National Institutes of Health
From atai Life Sciences
Via GlobeNewswire
News headline image
atai Life Sciences to Participate in September Investor Conferences
From atai Life Sciences
Via GlobeNewswire

Frequently Asked Questions

Is Atai Beckley N.V - Common Shares publicly traded?
Yes, Atai Beckley N.V - Common Shares is publicly traded.
What exchange does Atai Beckley N.V - Common Shares trade on?
Atai Beckley N.V - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Atai Beckley N.V - Common Shares?
The ticker symbol for Atai Beckley N.V - Common Shares is ATAI on the Nasdaq Stock Market
What is the current price of Atai Beckley N.V - Common Shares?
The current price of Atai Beckley N.V - Common Shares is 4.090
When was Atai Beckley N.V - Common Shares last traded?
The last trade of Atai Beckley N.V - Common Shares was at 12/26/25 02:02 PM ET
What is the market capitalization of Atai Beckley N.V - Common Shares?
The market capitalization of Atai Beckley N.V - Common Shares is 678.98M
How many shares of Atai Beckley N.V - Common Shares are outstanding?
Atai Beckley N.V - Common Shares has 679M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story